Difficulty: Medium
Average Score: 70%
Practice
Indicate the antiseizure drug, which is a sulfonamide derivative, blocking Na+ channels and having additional ability to inhibit T-type Ca2+ channels:
Correct answer
B
Rationale
In this question from the ATI Pharmacology Across the Lifespan exam, the correct answer is B) Zonisamide. Zonisamide is a sulfonamide derivative that blocks Na+ channels, which is a mechanism of action common to many antiseizure drugs. Additionally, zonisamide has the unique ability to inhibit T-type Ca2+ channels, contributing to its antiseizure effects.
Now, let's analyze why the other options are incorrect:
A) Tiagabine: Tiagabine works by inhibiting GABA reuptake rather than acting on Na+ or Ca2+ channels.
C) Ethosuximide: Ethosuximide is primarily used for absence seizures and works by blocking T-type Ca2+ channels, but it is not a sulfonamide derivative.
D) Primidone: Primidone is metabolized to phenobarbital and phenylethylmalonamide, which enhance GABAergic neurotransmission, but it does not block Na+ or Ca2+ channels.
Educational context: Understanding the mechanisms of action of antiseizure drugs is crucial for selecting the most appropriate treatment for patients with epilepsy. Knowing the specific properties of each drug allows healthcare providers to make informed decisions based on the patient's condition and individual needs. This knowledge also helps in managing potential side effects and drug interactions effectively.
Now, let's analyze why the other options are incorrect:
A) Tiagabine: Tiagabine works by inhibiting GABA reuptake rather than acting on Na+ or Ca2+ channels.
C) Ethosuximide: Ethosuximide is primarily used for absence seizures and works by blocking T-type Ca2+ channels, but it is not a sulfonamide derivative.
D) Primidone: Primidone is metabolized to phenobarbital and phenylethylmalonamide, which enhance GABAergic neurotransmission, but it does not block Na+ or Ca2+ channels.
Educational context: Understanding the mechanisms of action of antiseizure drugs is crucial for selecting the most appropriate treatment for patients with epilepsy. Knowing the specific properties of each drug allows healthcare providers to make informed decisions based on the patient's condition and individual needs. This knowledge also helps in managing potential side effects and drug interactions effectively.